Peter Kuebler
Impact in
- Virology top 2%
- HIV Research and Treatment
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Immunology 15
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 7
- Immunodeficiency and Autoimmune Disorders 3
- Immunotherapy and Immune Responses 3
- Hematology 10
- Hemophilia Treatment and Research 9
- Co-authors
- Douglas F. Nixon (14 shared papers)Amita Joshi (4 shared papers)Lisa Tuomi (2 shared papers)Lu Xu (1 shared paper)Steve Eppler (1 shared paper)Tong Lu (1 shared paper)Nelson L. ‘Shasha’ Jumbe (1 shared paper)Jianfeng Lü (1 shared paper)
- Journals
- Blood (5 papers)Journal of Thrombosis and Haemostasis (3 papers)Vaccine (3 papers)The Journal of Clinical Pharmacology (2 papers)Investigative Ophthalmology & Visual Science (2 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Peter Kuebler
31 papers receiving 947 citations
Peers
Comparison fields: 5 of 84
- Virology 255
- Immunology 418
- Ophthalmology 153
- Hematology 158
- Infectious Diseases 176
Countries citing papers authored by Peter Kuebler
This map shows the geographic impact of Peter Kuebler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kuebler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kuebler more than expected).
Fields of papers citing papers by Peter Kuebler
This network shows the impact of papers produced by Peter Kuebler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kuebler. The network helps show where Peter Kuebler may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Kuebler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 198 | |
| 2 | 2013 | 161 | |
| 3 | 1996 | 114 | |
| 4 | 2012 | 55 | |
| 5 | 2006 | 52 | |
| 6 | 2006 | 50 | |
| 7 | 2019 | 49 | |
| 8 | 2018 | 49 | |
| 9 | 2005 | 47 | |
| 10 | 2015 | 35 | |
| 11 | 2014 | 29 | |
| 12 | 1996 | 26 | |
| 13 | 2012 | 20 | |
| 14 | 2020 | 14 | |
| 15 | 2013 | 14 | |
| 16 | 2015 | 10 | |
| 17 | 2015 | 9 | |
| 18 | 2020 | 9 | |
| 19 | 2012 | 8 | |
| 20 | 2020 | 8 |
About Peter Kuebler
Peter Kuebler is a scholar working on Immunology, Hematology, Virology, Infectious Diseases and Molecular Biology, having authored 32 papers that have together received 995 indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (9 papers), Immune Cell Function and Interaction (9 papers), HIV Research and Treatment (8 papers), T-cell and B-cell Immunology (7 papers), HIV/AIDS Research and Interventions (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Immunotherapy and Immune Responses (3 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Virology (255 citations), Immunology (418 citations), Ophthalmology (153 citations), Hematology (158 citations) and Infectious Diseases (176 citations). Peter Kuebler has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Douglas F. Nixon, Amita Joshi, Lisa Tuomi, Lu Xu, Steve Eppler, Tong Lu, Nelson L. ‘Shasha’ Jumbe, Jianfeng Lü, Lisa A. Damico‐Beyer and Gabriel M. Ortiz. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Vaccine, The Journal of Clinical Pharmacology and Investigative Ophthalmology & Visual Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.